Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8405732 | 0.91 | HTT (0.37) | HTT | |
| SCHEMBL2349539 | 0.76 | HPGD (0.41) | TSHRALDH1A1HPGDHSD17B10HTT | |
| SCHEMBL8405525 | 0.72 | HSD17B10 (0.38) | ALDH1A1MAPTHPGDHSD17B10HTT | |
| SCHEMBL2166615 | 0.68 | HTT (0.41) | TSHRMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL8407690 | 0.68 | HTT (0.41) | HSD17B10HTT | |
| SCHEMBL7071218 | 0.66 | HTT (0.37) | TSHRMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL2894121 | 0.65 | TSHR (0.41) | TSHRMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL5699476 | 0.65 | TSHR (0.39) | TSHRMEN1ALDH1A1LMNAMAPT | |
| SCHEMBL8021224 | 0.62 | HTT (0.44) | TSHRMAPTHTTCYP2C19 | |
| SCHEMBL2164177 | 0.62 | HTT (0.56) | MEN1LMNAKMT2AHTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2039671-B1 | PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-08-31 | — | — | EP | disclosed |
| US-7652177-B2 | reacting 2,6-dichloro-4-(3,3-dichloro-2-propenyloxy)phenol with 3-bromo-1-propanol in a water insoluble solvent such as hexane, toluene, diethyl ether and a phase transfer catalyst ( tetrabutylammonium chloride) to produce 3-(2,6-dichloro-4-(3,3-dichloro-2-propenyloxy)phenoxy)-1-propyl alcohol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-26 | — | — | US | disclosed |
| US-20090192336-A1 | PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-30 | — | — | US | disclosed |
| EP-2039671-A1 | PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2009-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192336-A1 | PROCESS FOR PRODUCTION OF ALCOHOL COMPOUND | XDH, ADH1A, ADH5 | TSHR 1645/4885MEN1 4149/4885ALDH1A1 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.